Medicine Expenditure Trends in Côte D'ivoire
,
Abstract
Background: Expenditure related to medicines has increased significantly in several countries. This study aimed to describe medicine expenditure trends at the Mutual Insurance Company for Civil Servers and Agents of the State of Côte d’Ivoire (MUGEFCI) between 2014 and 2018. Methods: We conducted a retrospective analysis of the MUGEFCI's medicine expenditures. Beneficiaries who used at least one drug reimbursed between 1 January 2014 and 31 December 2018 were included in the study. Expenditure was estimated using public pharmacy prices. Beneficiaries were described by ATC class and age group. Results: In 2014, the medicine expenditure was XOF 14.720 billion (approximately € 22.44 million), which increased by 63.21% in 2018. The medicine classes that incurred the highest expenditures were, for the first level (ATC main group), anti-infectives for systemic use (23.84%), and cardiovascular medicines (15.23%). Anti-parasitic products, insecticides, and repellents (9.79%) and medicines for the alimentary tract and metabolism (9.67%) were also used. Total expenditure was most important for young adults aged 35-45 years. Conclusion: Medicine expenditures have increased significantly. The rational use of medicines and control of the expenditure they generate is a major challenge to guarantee access to medicines.French Republic. Ministry of Health and Access to Care. French Public Health Code.2022. Available at : https://sante.gouv.fr/soins-et-maladies/medicaments/le-bon-usage-des-medicaments/article/qu-est-ce-qu-un-medicament.
World Health Organisation. Regional Office for the Eastern Mediterranean. Essential medicines and pharmaceutical policies. Available at : https://www.emro.who.int/entity/essential-medicines/index.html
Cameron A, Ewen M, Ross-Degnan D, Ball D, Laing R. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis. Lancet. 17 janv 2009;373(9659):240‑9. DOI: 10.1016/S0140-6736(08)61762-6
Mendis S, Fukino K, Cameron A, Laing R, Filipe A, Khatib O, et al. The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries. Bull World Health Organ. avr 2007;85(4):279‑88. DOI: 10.2471/blt.06.033647
Niëns LM, Cameron A, Van de Poel E, Ewen M, Brouwer WBF, Laing R. Quantifying the impoverishing effects of purchasing medicines: a cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 31 août 2010;7(8):e1000333. DOI: 10.1371/journal.pmed.1000333
Belloni, A., D. Morgan et V. Paris (2016), « Pharmaceutical Expenditure And Policies : Past Trends And Future Challenges », Documents de travail de l'OCDE sur la santé, n° 87, Éditions OECD, Paris. https://doi.org/10.1787/5jm0q1f4cdq7-en.
Dormont, B. (2009). Health spending: a healthy increase? In Collection du CEPREMAP (p. 78). Paris: Rue d'Ulm
OECD (2021), Health at a Glance 2021 : OECD Indicators, Éditions OCDE, Paris, https://doi.org/10.1787/ae3016b9-en
Morgan SG. Prescription drug expenditures and population demographics. Health Serv Res. 2006 Apr;41(2):411-28. doi: 10.1111/j.1475-6773.2005.00495.x.
Gerdtham UG, Lundin D. Why did drug spending increase during the 1990s? A decomposition based on Swedish data. Pharmacoeconomics. 2004;22(1):29-42. doi: 10.2165/00019053-200422010-00003.
Conway A et al. The implications of regional and national demographic projections for future GMS costs in Ireland through to 2026. BMC Health Serv Res. 2014 Oct 21;14:477. doi: 10.1186/1472-6963-14-477.
Akunne, O.O., Adedapo, A.D.A. Antihypertensive prescription among black patients without compelling indications: prescription, effectiveness, quality and cost of medication. BMC Health Serv Res 19, 373 (2019). https://doi.org/10.1186/s12913-019-4202-2
Kafula MN, Ugburo E, Kibuule D. Consumption of psychotropic medicines at a referral hospital Namibia: findings and implications. Afri Health Sci. 2020; 20(2): 1000-1010. https://doi.org/10.4314/ahs.v20i2.57
Waelkens, Maria-Pia; Criel, Bart : Les mutuelles de sante en Afrique Sub-Saharienne - etat des lieux et reflexions sur un agenda de recherche (French). HNP Discussion Paper Washington, D.C. : World Bank Group. Available from: http://documents.worldbank.org/curated/en/493721468768693061/Les-mutuelles-de-sante-en-Afrique-Sub-Saharienne-etat-des-lieux-et-reflexions-sur-un-agenda-de-recherche
Mutual Insurance Company for civil servants and agents of the State of Côte d’Ivoire (MUGEFCI). Aivalable from : https://www.mugef-ci.com/
World Health Organisation. The Anatomical Therapeutic Chemical (ATC) classification system, structure and principles. Oslo: WHO Collaborating Centre for Drug Statistics Methodology. 2022. Available from: https://www.who.int/tools/atc-ddd-toolkit/atc-classification
World Bank Group. Open data about Côte d’Ivoire. 2022. Available from ; https://data.worldbank.org/country/cote-divoire?view=chart
Kim Y, Chae J, Shin S, Jo G, Shin J, Kim B, Kim DS, Lee JY. Trends in National Pharmaceutical Expenditure in Korea during 2011 - 2020. Infect Chemother. 2023 Jun;55(2):237-246. doi: 10.3947/ic.2023.0028
Mousnad MA, Palaian S, Shafie AA, Mohamed Ibrahim MI. Medicine Expenditure and Trends in National Health Insurance Funds Sudan. J Pharm Pract Community Med. 2018;4(3):144-9. DOI: 10.5530/jppcm.2018.3.34
Lenihan AC, Woods N (2015) Irish GMS Cost Projections and Its Implications between 2016 and 2026. Pharmacoeconomics 1:101. Doi: 10.4172/2472-1042.1000101
Fernández-Liz E, Modamio P, Catalán A, Lastra CF, Rodríguez T, Mariño EL. Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain. Br J Clin Pharmacol. 2008 Mar;65(3):407-17. doi: 10.1111/j.1365-2125.2007.03029.x.
Mueller C, Schur C, O'Connell J. Prescription drug spending: the impact of age and chronic disease status. Am J Public Health. 1997 Oct;87(10):1626-9. doi: 10.2105/ajph.87.10.1626.
Steinberg EP, Gutierrez B, Momani A, Boscarino JA, Neuman P, Deverka P. Beyond survey data: a claims-based analysis of drug use and spending by the elderly. Health Aff (Millwood). 2000 Mar-Apr;19(2):198-211. doi: 10.1377/hlthaff.19.2.198.
| Files | ||
| Issue | Vol 10 No 4 (2024) | |
| Section | Original Article(s) | |
| Keywords | ||
| Medicine expenditure, ATC system, Africa, Mutual insurance Company, Retrospective analysis | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
